A synthetic NKG2A engager enables long-term persistence of HLA-deficient allogeneic engineered Tregs - Tingxi Guo; Kaya R Epstein; Maegan E Hoover; Nathan W Zammit; Jennifer Y Yam; Scott Hussell; Sophia Hernandez; Abigail Doherty; Payam Zarin; Martina Sassone-Corsi; Lindsay Webb; Gene I Uenishi; et al. (EMBO Molecular Medicine, 2026)